Harmony Biosciences Holdings, Inc. - Common Stock (HRMY)

CUSIP: 413197104

Q3 2025 13F Holders as of 30 Sep 2025

Security identity
Shares outstanding
57,644,670
Holder snapshot
Share change
-3,982,528
Put/Call ratio
30%
Reported price per share
$27.56
Number of holders
292
Value change
-$112,498,749
Number of buys
156
Number of sells
112

Security key

413197104

Report period

Q3 2025

Institutions

292

Top holders

10

Ownership snapshot

Top reported holders of HRMY - Harmony Biosciences Holdings, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Lead holder
Marshman Fund Trust II
13D/G signal
Marshman Fund Trust II
Evidence rows
15
Latest as of
28 Aug 2025
3/4/5 13D/G 13F Lead comparable stake: 11% 13D/G row: Marshman Fund Trust II Showing 1-6 of 15 holder rows.
Holder Evidence Ownership % Position 12M Net Δ As of
Marshman Fund Trust II
3/4/5 13D/G
10%+ Owner
11%
from 13D/G
$183,364,064
6,051,120 shares
01 Nov 2024
BlackRock, Inc.
13F 13D/G
Company
10%
from 13D/G
$212,887,273
6,736,939 shares
30 Jun 2025
Valor IV Pharma Holdings, LLC
3/4/5
10%+ Owner
0.04%
$834,732
23,714 shares
28 Aug 2025
Valor Management LLC
13F
Company
13F
11%
$209,129,843
6,618,033 shares
30 Jun 2025
VANGUARD GROUP INC
13F
Company
13F
8.9%
$161,500,648
5,110,780 shares
30 Jun 2025
FMR LLC
13F
Company
13F
8.1%
$148,146,870
4,688,192 shares
30 Jun 2025
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q3 2025

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
292
Shares
47,339,126
Rows available
292
Investor Option Weight % Change % Reported value * Price Shares Share Change Activity Report Period

* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.

Compare Q3 2025 vs Q2 2025 Across Filers

Q2 2025 holders
276
Q3 2025 holders
292
Holder diff
16
Investor Q2 2025 Shares Q3 2025 Shares Share Diff Share Chg % Q2 2025 value Q3 2025 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .